Author correction. Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4)
- PMID: 26028626
- PMCID: PMC4975047
- DOI: 10.1183/09031936.50136014
Author correction. Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4)
Abstract
“Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2–4).” Roland Buhl, François Maltais, Roger Abrahams, Leif Bjermer, Eric Derom, Gary Ferguson, Matjaž Fležar, Jacques Hébert, Lorcan McGarvey, Emilio Pizzichini, Jim Reid, Antony Veale, Lars Grönke, Alan Hamilton, Lawrence Korducki, Kay Tetzlaff, Stella Waitere-Wijker, Henrik Watz and Eric Bateman. Eur Respir J 2015; 45: 969–979.
Erratum for
-
Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4).Eur Respir J. 2015 Apr;45(4):969-79. doi: 10.1183/09031936.00136014. Epub 2015 Jan 8. Eur Respir J. 2015. PMID: 25573406 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources